Document is current
Any future updates will be listed below
-
Authors
Harinath, Girish
Lee, Virginia
Nyquist, Andy
Moel, Mauricio
Wouters, Maartje
Hagemeier, Jesper
Verkennes, Brandon
Tacubao, Colleen
Nasher, Sayem
Kauppi, Krister
Morgan, Stefanie L. https://orcid.org/0000-0003-3689-3333
Isman, Anar
Zalzala, Sajad
-
Funding
Funding for this research was provided by:
AgelessRx
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 16 January 2025
First Online: 28 January 2025
Declarations
:
: This study was approved by the Institutional Review Board of the Institute of Regenerative and Cellular Medicine (IRCM, approval number IRCM-2022–352), and was conducted in accordance with Good Clinical Practice (GCP) standards. Informed consent and consent to use de-identified information for research and research publication purposes were obtained from all participants.
: All participants and authors consented to publish the data contained in this manuscript.
: GH, VL, AN, MM, BV, CT, SN, SLM, AI, and SZ are employees and shareholders of AgelessRx. MW and JH have received financial compensation from AgelessRx for their contributions. KK is an employee and shareholder of Venture Plant AB and Rapamycin Longevity Lab, which has received a donation from AgelessRx for research coordination in partnership with Ora Biomedical.
